Elevated fibroblast growth factor-inducible 14 expression promotes gastric cancer growth via nuclear factor-κB and is associated with poor patient outcome

Cancer Letters

Volumn 314, Issue 1, 2012, Pages 73-81

  Kwon, Oh Hyung ^a,b   Park, Sung Joon ^a,c   Kang, Tae Wook ^a   Kim, Mirang ^a   Kim, Jeong Hwan ^a   Noh, Seung Moo ^b   Song, Kyu Sang ^b   Yoo, Hyang Sook ^a   Wang, Yuli ^d   Pocalyko, David ^d   Paik, Sang Gi ^b   Kim, Yeul Hong ^c   Kim, Seon Young ^a   Kim, Yong Sung ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chungnam National University   (South Korea)

^c Korea University   (South Korea)

^d PFIZER INC   (United States)

Author keywords

Anti apoptosis; Cell growth; Fn14; Gastric cancer; NF B

Indexed keywords

FIBROBLAST GROWTH FACTOR INDUCIBLE 14 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BCL XL GENE; CANCER CELL; CANCER SURVIVAL; CELL GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROBLAST GROWTH FACTOR INDUCIBLE 14 GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIGENE FAMILY; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSCRIPTION REGULATION;

BCL-X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NF-KAPPA B; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; STOMACH NEOPLASMS; TREATMENT OUTCOME; TUMOR NECROSIS FACTORS;

EID: 82355175278     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.09.016     Document Type: Article

References (38)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 1999, 80:827-841.
2. Silverman N., Maniatis T. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 2001, 15:2321-2342.
3. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 2002, 3:221-227.
4. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006, 441:431-436.
5. Joyce D., Albanese C., Steer J., Fu M., Bouzahzah B., Pestell R.G. NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev. 2001, 12:73-90.
6. Huang Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene 2000, 19:6627-6631.
7. Werner A.B., de Vries E., Tait S.W., Bontjer I., Borst J. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. J. Biol. Chem. 2002, 277:22781-22788.
8. Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002, 108:153-164.
9. Reed J.C. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 1999, 17:2941-2953.
10. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431:461-466.
11. Meighan-Mantha R.L., Hsu D.K., Guo Y., Brown S.A., Feng S.L., Peifley K.A., Alberts G.F., Copeland N.G., Gilbert D.J., Jenkins N.A., Richards C.M., Winkles J.A. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J. Biol. Chem. 1999, 274:33166-33176.
12. Feng S.L., Guo Y., Factor V.M., Thorgeirsson S.S., Bell D.W., Testa J.R., Peifley K.A., Winkles J.A. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am. J. Pathol. 2000, 156:1253-1261.
13. Wiley S.R., Cassiano L., Lofton T., Davis-Smith T., Winkles J.A., Lindner V., Liu H., Daniel T.O., Smith C.A., Fanslow W.C. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 2001, 15:837-846.
14. Tran N.L., McDonough W.S., Donohue P.J., Winkles J.A., Berens T.J., Ross K.R., Hoelzinger D.B., Beaudry C., Coons S.W., Berens M.E. The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. Am. J. Pathol. 2003, 162:1313-1321.
15. Han H., Bearss D.J., Browne L.W., Calaluce R., Nagle R.B., Von Hoff D.D. Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res. 2002, 62:2890-2896.
16. Tran N.L., McDonough W.S., Savitch B.A., Sawyer T.F., Winkles J.A., Berens M.E. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression. J. Biol. Chem. 2005, 280:3483-3492.
17. Kawakita T., Shiraki K., Yamanaka Y., Yamaguchi Y., Saitou Y., Enokimura N., Yamamoto N., Okano H., Sugimoto K., Murata K., Nakano T. Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis. Biochem. Biophys. Res. Commun. 2004, 318:726-733.
18. Brown S.A., Richards C.M., Hanscom H.N., Feng S.L., Winkles J.A. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Biochem. J. 2003, 371:395-403.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
20. Shin G.S., Kang T.W., Yang S.J., Baek S.J., Jeong Y.S., Kim S.Y. GENT: Gene Expression Database of Normal and Tumor Tissues. Cancer Informat. 2011, 10:149-157.
21. Han S., Yoon K., Lee K., Kim K., Jang H., Lee N.K., Hwang K., Young Lee S. TNF-related weak inducer of apoptosis receptor a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors. Biochem. Biophys. Res. Commun. 2003, 305:789-796.
22. Yemelyanov A., Gasparian A., Lindholm P., Dang L., Pierce J.W., Kisseljov F., Karseladze A., Budunova I. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. Oncogene 2006, 25:387-398.
23. Smith C.A., Farrah T., Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation costimulation, and death. Cell 1994, 76:959-962.
24. Michaelson J.S., Cho S., Browning B., Zheng T.S., Lincecum J.M., Wang M.Z., Hsu Y.M., Burkly L.C. Tweak induces mammary epithelial branching morphogenesis. Oncogene 2005, 24:2613-2624.
25. Winkles J.A. The TWEAK-Fn14 cytokine-receptor axis: discovery Biology and therapeutic targeting. Nat. Rev. Drug Discov. 2008, 7:411-425.
26. Winkles J.A., Tran N.L., Berens M.E. TWEAK and Fn14: new molecular targets for cancer therapy?. Cancer Lett. 2006, 235:11-17.
27. Tran N.L., McDonough W.S., Savitch B.A., Fortin S.P., Winkles J.A., Symons M., Nakada M., Cunliffe H.E., Hostetter G., Hoelzinger D.B., Rennert J.L., Michaelson J.S., Burkly L.C., Lipinski C.A., Loftus J.C., Mariani L., Berens M.E. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome. Cancer Res. 2006, 66:9535-9542.
28. Watts G.S., Tran N.L., Berens M.E., Bhattacharyya A.K., Nelson M.A., Montgomery E.A., Sampliner R.E. Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma. Int. J. Cancer 2007, 121:2132-2139.
29. Willis A.L., Tran N.L., Chatigny J.M., Charlton N., Vu H., Brown S.A., Black M.A., McDonough W.S., Fortin S.P., Niska J.R., Winkles J.A., Cunliffe H.E. The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity. Mol. Cancer Res. 2008, 6:725-734.
30. Chiao P.J., Na R., Niu J., Sclabas G.M., Dong Q., Curley S.A. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells. Cancer 2002, 95:1696-1705.
31. Tai D.I., Tsai S.L., Chang Y.H., Huang S.N., Chen T.C., Chang K.S., Liaw Y.F. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 2000, 89:2274-2281.
32. Weaver K.D., Yeyeodu S., Cusack J.C., Baldwin A.S., Ewend M.G. Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas. J. Neurooncol. 2003, 61:187-196.
33. Escarcega R.O., Fuentes-Alexandro S., Garcia-Carrasco M., Gatica A., Zamora A. The transcription factor nuclear factor-kappa B and cancer. Clin. Oncol. 2007, 19:154-161. (R Coll Radiol).
34. Garg A., Aggarwal B.B. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002, 16:1053-1068.
35. Saitoh T., Nakayama M., Nakano H., Yagita H., Yamamoto N., Yamaoka S. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J. Biol. Chem. 2003, 278:36005-36012.
36. Oliver L., Tremblais K., Guriec N., Martin S., Meflah K., Menanteau J., Vallette F.M. Influence of bcl-2-related proteins on matrix metalloproteinase expression in a rat glioma cell line. Biochem. Biophys. Res. Commun. 2000, 273:411-416.
37. Zhu H., Guo W., Zhang L., Davis J.J., Teraishi F., Wu S., Cao X., Daniel J., Smythe W.R., Fang B. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells. Mol. Cancer Therapeut. 2005, 4:451-456.
38. Bo J., Yang G., Huo K., Jiang H., Zhang L., Liu D., Huang Y. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 2011.